Corina Thomet

Corina Thomet

Auto-generated profile, based on publicly available information

Corina Thomet

Siloah BESAS, Bern Hospital Center for Geriatric Medicine , Worbstrasse 316, Gümligen, Bern 3073

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2020 in European Heart Journal
Verified
Journal Article
Closed access
MSMarkus Schwerzmann
Markus Schwerzmann
EGEva Goossens
Eva Goossens
PGPastora Gallego
Pastora Gallego
AKAdrienne H Kovacs
Adrienne H Kovacs
PMPhilip Moons
Philip Moons
CTCorina Thomet
Corina Thomet
Survival prospects in adults with congenital heart disease (CHD), although improved in recent decades, still remain below expectations for the general population. Patients and their loved ones benefit from preparation for both unexpected and predictable deaths, sometimes preceded by a prolonged period of declining health. Hence, advance care planning (ACP) is an integral part of comprehensive care for adults with CHD. This position paper summarizes evidence regarding benefits of and patients’ preferences for ACP and provides practical advice regarding the implementation of ACP processes within clinical adult CHD practice. We suggest that ACP be delivered as a structured process across different stages, with content dependent upon the anticipated disease progression. We acknowledge potential barriers to initiate ACP discussions and emphasize the importance of a sensitive and situation-specific communication style. Conclusions presented in this article reflect agreed expert opinions and include both patient and provider perspectives.

1 October 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
JRJessica Rassart
Jessica Rassart
SASilke Apers
Silke Apers
AKAdrienne H. Kovacs
Adrienne H. Kovacs
PMPhilip Moons
Philip Moons
CTCorina Thomet
Corina Thomet
KLKoen Luyckx
Koen Luyckx

1 December 2019 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
PMPhilip Moons
Philip Moons
KLKoen Luyckx
Koen Luyckx
AKAdrienne H. Kovacs
Adrienne H. Kovacs
CHChristina E. Holbein
Christina E. Holbein
CTCorina Thomet
Corina Thomet
SASilke Apers
Silke Apers

23 May 2016 in Heart
Verified
Journal Article
Closed access
PDF file
RSRoger Staempfli
Roger Staempfli
JSJean-Paul Schmid
Jean-Paul Schmid
SSStephan Schenker
Stephan Schenker
PEPrisca Eser
Prisca Eser
LTLukas D Trachsel
Lukas D Trachsel
MSMarkus Schwerzmann
Markus Schwerzmann
Objective High altitude-related hypoxia induces pulmonary vasoconstriction. In Fontan patients without a contractile subpulmonary ventricle, an increase in pulmonary artery pressure is expected to decrease circulatory output and reduce exercise capacity. This study investigates the direct effects of short-term high altitude exposure on pulmonary blood flow (PBF) and exercise capacity in Fontan patients. Methods 16 adult Fontan patients (mean age 28±7 years, 56% female) and 14 matched controls underwent cardiopulmonary exercise testing with measurement of PBF with a gas rebreathing system at 540 m (low altitude) and at 3454 m (high altitude) within 12 weeks. Results PBF at rest and at exercise was higher in controls than in Fontan patients, both at low and high altitude. PBF increased twofold in Fontan patients and 2.8-fold in the control group during submaximal exercise, with no significant difference between low and high altitude (p=0.290). A reduction in peak oxygen uptake at high compared with low altitude was observed in Fontan patients (22.8±5.1 and 20.5±3.8 mL/min/kg, p<0.001) and the control group (35.0±7.4 and 29.1±6.5 mL/min/kg, p<0.001). The reduction in exercise capacity was less pronounced in Fontan patients compared with controls (9±12% vs 17±8%, p=0.005). No major adverse clinical event was observed. Conclusions Short-term high altitude exposure has no negative impact on PBF and exercise capacity in Fontan patients when compared with controls, and was clinically well tolerated. Trial registration number NCT02237274: Results.

1 April 2021 in The American Journal of Cardiology
Verified
Journal Article
Open access
PMPhilip Moons
Philip Moons
KLKoen Luyckx
Koen Luyckx
CTCorina Thomet
Corina Thomet
WBWerner Budts
Werner Budts
JEJunko Enomoto
Junko Enomoto
AKAdrienne H. Kovacs
Adrienne H. Kovacs
In this international study, we (1) compared patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) who had versus had not been hospitalized during the previous 12 month, (2) contrasted PROs in patients who had been hospitalized for cardiac surgery versus nonsurgical reasons, (3) assessed the magnitude of differences between the groups (i.e., effect sizes), and (4) explored differential effect sizes between countries. APPROACH-IS was a cross-sectional, observational study that enrolled 4,028 patients from 15 countries (median age 32 years; 53% females). Self-report questionnaires were administered to measure PROs: health status; anxiety and depression; and quality of life. Overall, 668 patients (17%) had been hospitalized in the previous 12 months. These patients reported poorer outcomes on all PROs, with the exception of anxiety. Patients who underwent cardiac surgery demonstrated a better quality of life compared with those who were hospitalized for nonsurgical reasons. For significant differences, the effect sizes were small, whereas they were negligible in nonsignificant comparisons. Substantial intercountry differences were observed. For various PROs, moderate to large effect sizes were found comparing different countries. In conclusion, adults with CHD who had undergone hospitalization in the previous year had poorer PROs than those who were medically stable. Researchers ought to account for the timing of recruitment when conducting PRO research as hospitalization can impact results.

1 March 2019 in IJC Heart & Vasculature
Verified
Journal Article
Open access
LLLena Larsson
Lena Larsson
BJBengt Johansson
Bengt Johansson
CSCamilla Sandberg
Camilla Sandberg
SASilke Apers
Silke Apers
AKAdrienne H. Kovacs
Adrienne H. Kovacs
PMPhilip Moons
Philip Moons
Background: Physical activity is important to maintain and promote health. This is of particular interest in patients with congenital heart disease (CHD) where acquired heart disease should be prevented. The World Health Organization (WHO) recommends a minimum of 2.5 h/week of physical activity exceeding 3 metabolic equivalents (METS) to achieve positive health effects. It is unknown whether physical activity levels (PAL) in adult CHD patients differ by country of origin. Methods: 3896 adults with CHD recruited from 15 countries over 5 continents completed self-reported instruments, including the Health Behaviour Scale (HBS-CHD), within the APPROACH-IS project. For each patient, we calculated whether WHO recommendations were achieved or not. Associated factors were investigated using Generalized Linear Mixed Models. Results: On average, 31% reached the WHO recommendations but with a great variation between geographical areas (India: 10%-Norway: 53%). Predictors for physical activity level in line with the WHO recommendations, with country of residence as random effect, were male sex (OR 1.78, 95% CI 1.52-2.08), NYHA-class I (OR 3.10, 95% CI 1.71-5.62) and less complex disease (OR 1.46, 95% CI 1.16-1.83). In contrast, older age (OR 0.97, 95% CI 0.96-0.98), lower educational level (OR 0.41, 95% CI 0.26-0.64) and being unemployed (OR 0.57, 95% CI 0.420.77) were negatively associated with reaching WHO recommendations. Conclusions: A significant proportion of patients with CHD did not reach theWHO physical activity recommendations. There was a large variation in physical activity level by country of origin. Based on identified predictors, vulnerable patients may be identified and offered specific behavioral interventions. (c) 2018 The Authors. Published by Elsevier B.V.